Reviva Pharmaceuticals Holdings, Inc. (RVPH)

3.2000 +0.0200 (+0.63%) At close: 04:00PM EDT

Reviva Pharmaceuticals Holdings, Inc.

10080 N. Wolfe Road
Suite SW3-200
Cupertino, CA 95014
United States
408-501-8881
https://www.revivapharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 15

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Laxminarayan Bhat Ph.D.	Founder, CEO, President & Director	450k	N/A	1965
Mr. Narayan Prabhu	Chief Financial Officer	325k	N/A	1972

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.

Corporate Governance

Reviva Pharmaceuticals Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.